Citations

Merck & co. (17)

Number	Title	Issue Date
6586424	Tyrosine kinase inhibitors	2003/07/01
6245759	Tyrosine kinase inhibitors	2001/06/12
6306874	Tyrosine kinase inhibitors	2001/10/23
6313138	Tyrosine kinase inhibitors	2001/11/06
6316444	SRC kinase inhibitor compounds	2001/11/13
6329380	SRC kinase inhibitor compounds	2001/12/11
6420382	Tyrosine kinase inhibitors	2002/07/16
10/062351	Tyrosine kinase inhibitors	2002/10/10
6479512	Tyrosine kinase inhibitors	2002/11/12
6498165	Src kinase inhibitor compounds	2002/12/24
6544988	Tyrosine kinase inhibitors	2003/04/08
6958340	Tyrosine kinase inhibitors	2005/10/25
6927293	Tyrosine kinase inhibitors	2005/08/09
6875767	(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors	2005/04/05
6875767	(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors	2005/04/05
6794393	Tyrosine kinase inhibitors	2004/09/21
6586423	Tyrosine kinase inhibitors	2003/07/01

Sugen (6)

Number	Title	Issue Date
5886020	3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease	1999/03/23
5883116	3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease	1999/03/16
5883113	3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease	1999/03/16
5834504	3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease	1998/11/10
5804396	Assay for agents active in proliferative disorders	1998/09/08
5792783	3-heteroaryl-2-indolinone compounds for the treatment of disease	1998/08/11

Pfizer (4)

Number	Title	Issue Date
6562818	Irreversible inhibitors of tyrosine kinases	2003/05/13
6344459	Irreversible inhibitors of tyrosine kinases	2002/02/05
6127374	Irreversible inhibitors of tyrosine kinases	2000/10/03
5639757	4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors	1997/06/17

Human Genome Sciences (2)

Number	Title	Issue Date
11/614212	Antibodies Against Tumor Necrosis Factor Delta (APRIL)	2007/07/12
7189820	Antibodies against tumor necrosis factor delta (APRIL)	2007/03/13

Sanofi-aventis (2)

Number	Title	Issue Date
5710158	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase	1998/01/20
5714493	Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase	1998/02/03

Rhone-Poulenc Rorer Pharmaceuticals (1)

Number	Title	Issue Date
5656643	Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase	1997/08/12

Sankyo (1)

Number	Title	Issue Date
4464375	4-Anilinoquinazoline compounds and pharmaceutical compositions thereof	1984/08/07

Mead Johnson Nutrition (1)

Number	Title	Issue Date
4343940	Anti-tumor quinazoline compounds	1982/08/10

Cancer Research Campaign Technology (1)

Number	Title	Issue Date
5728868	Prodrugs of protein tyrosine kinase inhibitors	1998/03/17

Board of Regents, the University of Texas System (1)

Number	Title	Issue Date
6100254	Inhibitors of protein tyrosine kinases	2000/08/08

The Trustees of The University Of Pennsylvania (1)

Number	Title	Issue Date
6740665	Tyrosine kinase inhibitors and methods of using the same	2004/05/25

Regents of the University of California, The (1)

Number	Title	Issue Date
6100254	Inhibitors of protein tyrosine kinases	2000/08/08

Mitsubishi Chemical (1)

Number	Title	Issue Date
5618829	Tyrosine kinase inhibitors and benzoylacrylamide derivatives	1997/04/08

AVENTISUB INC. (1)

Number	Title	Issue Date
5721237	Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties	1998/02/24

NA (1)

Number	Title	Issue Date
12/367093	TRYPANOSOME MICROSOME SYSTEM AND USES THEREOF	2009/08/13

UBE Industries, (1)

Number	Title	Issue Date
4464375	4-Anilinoquinazoline compounds and pharmaceutical compositions thereof	1984/08/07

Novartis (1)

Number	Title	Issue Date
5521184	Pyrimidine derivatives and processes for the preparation thereof	1996/05/28

University of Connecticut (1)

Number	Title	Issue Date
6984389	Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality	2006/01/10